PDB41 COST-UTILITY OF INSULIN GLARGINE IN COMBINATION THERAPY WITH ORAL AGENTS COMPARED WITH PREMIX INSULIN WITH OR WITHOUT OF ORAL AGENTS IN TYPE 2 DIABETES. THE POLISH PERSPECTIVE
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75019-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)75019-1/fulltext
Title :
PDB41 COST-UTILITY OF INSULIN GLARGINE IN COMBINATION THERAPY WITH ORAL AGENTS COMPARED WITH PREMIX INSULIN WITH OR WITHOUT OF ORAL AGENTS IN TYPE 2 DIABETES. THE POLISH PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75019-1&doi=10.1016/S1098-3015(10)75019-1
First page :
Section Title :
Open access? :
No
Section Order :
947